Patients Validating medications: A consumer responsibility? Access to medications is a vital aspect of maintaining healthy lives, and the urge to invest in personal health has only grown since the COVID-19 pandemic.
Partner Content Partner Content KOL Validation: An Opportunity To Benchmark Mindset The benefits of conducting a regular KOL validation exercise to refresh your KOL list are well established.
Partner Content Partner Content Experts to come together for compliance event Experts to come together for compliance event
Partner Content Partner Content Validating Your KOLs Validating your KOLs for an evolving KOL landscape
News Chiesi signs $1.9bn deal to buy KalVista and its HAE drug Chiesi has boosted its rare disease business with an agreement to buy KalVista and Ekterly, its oral drug for treating attacks in rare disease HAE.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.